List. liquid) does not have an generic FDA “A”-rated equivalent. Reyataz # (atazanavir) PA Prior authorization is required. The prescriber must obtain prior authorization for the drug in Updated MassHealth order for the pharmacy to receive payment. Note: Drug List Prior authorization applies to both the and the generic equivalent FDA “A”-rated Effective September 10, 2018, the following of listed product. nutrient product will be added to the MassHealth BP Brand Preferred over generic equivalents. In Over-the-Counter Drug List. general, MassHealth requires a trial of the glucose products < 19 years preferred drug or clinical rationale for prescribing the non-preferred drug generic equivalent. Abbreviations, Acronyms, and PD Preferred Drug. In general, MassHealth Symbols requires a trial of the preferred drug or clinical rationale for prescribing a non-preferred drug # This designates a brand-name drug with FDA within a therapeutic class. generic equivalents. Prior authorization “A”-rated is required for the brand, unless a particular form of that drug (for example, tablet, capsule, or
List. Reyataz # (atazanavir) Updated MassHealth Drug List Effective September 10, 2018, the following nutrient product will be added to the MassHealth Over-the-Counter Drug List. glucose products < 19 years Abbreviations, Acronyms, and Symbols # This designates a brand-name drug with FDA “A”-rated generic equivalents. Prior authorization is required for the brand, unless a particular form of that drug (for example, tablet, capsule, or liquid) does not have an FDA “A”-rated generic equivalent. PA Prior authorization is required. The prescriber must obtain prior authorization for the drug in order for the pharmacy to receive payment. Note: Prior authorization applies to both the and the FDA “A”-rated generic equivalent of listed product. BP Brand Preferred over generic equivalents. In general, MassHealth requires a trial of the preferred drug or clinical rationale for prescribing the non-preferred drug generic equivalent. PD Preferred Drug. In general, MassHealth requires a trial of the preferred drug or clinical rationale for prescribing a non-preferred drug within a therapeutic class.
pharmacy-facts%20119.docx